Venous thromboembolism incidence appeared high among patients with solid tumors who had implanted ports, according to study results. Risk factors for catheter-related VTE differed from the factors ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Slow release of concentrated ranibizumab via a surgically implanted port delivery system demonstrated ...

Retrospective studies suggest that it may be safe to extend the maintenance flushing interval of implanted ports from once every month, as recommended by the manufacturer, to once every 3 months, but ...

The study was performed according to the second principles of the Declaration of Helsinki. The study was retrospectively reviewed and approved by the Ethical Committee of the Veneto Institute of ...

June 26, 2007 — The US Food and Drug Administration (FDA) has granted premarket approval for a neurostimulation lead for chronic pain management, and 510(k) clearance for power injectable ports and ...

ORLANDO, Fla.--(BUSINESS WIRE)--3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with ...

Berger Montague has been contacted by hundreds of individuals alleging injuries by Bard port catheters. The consolidated lawsuits involve personal injuries arising from Bard's alleged defective design ...